Related Experiment Video

Updated: Feb 7, 2026

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model
09:29

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model

Published on: March 20, 2020

18.9K

Future Developments in Neoadjuvant Therapy for Triple-Negative Breast Cancer

Lakisha Moore-Smith1, Andres Forero-Torres2, Erica Stringer-Reasor3

  • 1Department of Medicine, Brookwood Baptist Health - Princeton, 833 Princeton Avenue, POB III Suite 200, Birmingham, AL 35211-1311, USA.

The Surgical Clinics of North America
|July 15, 2018
PubMed

Insights

Triple-negative breast cancer (TNBC) remains a deadly subtype with few treatment options. Genomic profiling offers new hope for developing targeted therapies to improve patient outcomes.

Area of Science:

  • Oncology
  • Genomics
  • Cancer Research

Background:

  • Breast cancer is a leading cause of cancer death in women.
  • Triple-negative breast cancer (TNBC) presents unique challenges due to limited targeted treatment options compared to other subtypes.
  • Advances in targeted therapies have largely excluded TNBC, highlighting an unmet clinical need.

Purpose of the Study:

  • To explore the potential of genomic profiling in identifying novel therapeutic targets for TNBC.
  • To investigate the efficacy of personalized targeted agents in the neoadjuvant setting for TNBC patients.
  • To understand mechanisms of resistance to current and novel therapies in TNBC.

Main Methods:

  • Genomic profiling of TNBC tumors to identify actionable mutations and molecular alterations.
  • Application of personalized targeted agents in the neoadjuvant treatment setting.
  • Analysis of treatment response and resistance mechanisms through molecular and clinical data.

Main Results:

  • Genomic profiling revealed promising molecular targets for TNBC.
  • Personalized therapies demonstrated potential in the neoadjuvant setting, warranting further investigation.
  • Insights into resistance mechanisms were gained, crucial for future treatment strategies.

Conclusions:

  • Genomic profiling is a valuable tool for advancing TNBC treatment.
  • Targeted therapies in the neoadjuvant setting hold promise for improving TNBC patient outcomes.
  • Further research into molecular-based therapies is essential for overcoming treatment resistance in TNBC.
Keywords:
Early stage breast cancerNeoadjuvant chemotherapyTargeted therapyTriple-negative breast cancer

More Related Videos

Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy09:01

Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy

Published on: May 22, 2020

3.6K
Modeling Breast Cancer in Human Breast Tissue using a Microphysiological System10:51

Modeling Breast Cancer in Human Breast Tissue using a Microphysiological System

Published on: April 23, 2021

4.7K

Related Concept Videos

Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.2K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.9K
Scalar and Vector Triple Products01:06

Scalar and Vector Triple Products

Two vectors can be multiplied using a scalar product or a vector product. The resultant of a scalar product is scalar, while with vector products, the resultant is a vector. These rules of the scalar or vector product between two vectors can be applied to multiple vectors to obtain meaningful combinations. The scalar triple product is the dot product of a vector with the cross product of two vectors.
The scalar triple product is the dot product of a vector with the cross product of two vectors....
4.5K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
38.6K
Positive, Negative, and Zero Work00:58

Positive, Negative, and Zero Work

Work is done on an object when energy is transferred to the object. In other words, work is done when a force acts on a body that undergoes a displacement from one position to another. By definition, the work done by a force is the integral of the force with respect to the displacement along its path. Forces can vary as a function of position, and displacements can occur along various paths between two points. The magnitude of a force multiplied by the cosine of the angle that the force makes...
22.2K
Sustainable Development01:43

Sustainable Development

As the human population continues to grow and use resources, we must be mindful of our planet’s natural limits. Sustainable development provides a pathway to maintain and improve human life now while also ensuring that future generations will have the resources that they need. The long-term success of sustainability efforts rests on understanding the interplay between human actions and ecological systems.
15.2K